Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO ISO-GHD Study
2007-000790-36Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Dec 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in growth hormone deficiency (GHD) comparing Somatropin with Placebo (2 arms). Primary endpoint: Change in visceral fat mass. Started Dec 2007; status: terminated.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on 2007-000790-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000790-36.